Structure-Based Design of Selective beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2.
Fujimoto, K., Matsuoka, E., Asada, N., Tadano, G., Yamamoto, T., Nakahara, K., Fuchino, K., Ito, H., Kanegawa, N., Moechars, D., Gijsen, H.J.M., Kusakabe, K.I.(2019) J Med Chem 62: 5080-5095
- PubMed: 31021626 
- DOI: 10.1021/acs.jmedchem.9b00309
- Primary Citation of Related Structures:  
6JSE, 6JSF, 6JSG, 6JSN, 6JSZ - PubMed Abstract: 
BACE1 inhibitors hold potential as agents in disease-modifying treatment for Alzheimer's disease. BACE2 cleaves the melanocyte protein PMEL in pigment cells of the skin and eye, generating melanin pigments. This role of BACE2 implies that nonselective and chronic inhibition of BACE1 may cause side effects derived from BACE2 ...